HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.

Abstract
The post-treatment status of breast cancer survivors has become a concern because of the toxicity induced by chemotherapeutic agents in the brain tissues resulting in cognitive deficits, which is generally referred as chemobrain. The aim of this study was to assess the effect of a proprietary ayurvedic formulation Mulmina Mango against chemotherapy-induced cognitive impairment (CICI). Mammary carcinoma was induced by subcutaneously inoculating 4T1 cells into the mammary fat pad of the animals. Intraperitoneal administration of Cyclophosphamide, Methotrexate, 5-Fluorouracil (CMF) regimen was carried out once a week for three weeks. Treatment of Mulmina began one week before chemotherapy and continued till the end of the chemotherapy cycle. After three cycles of chemotherapy, cognitive decline was assessed by Morris water maze task followed by assessment of locomotor activity by open-field test. Tumor progression was evaluated by measurement of tumor volume. Oxidative and neuroinflammatory markers were also evaluated from the isolated brain samples. CMF treatment resulted in a considerable reduction in tumour volume. We found chemotherapy negatively affected behavioral and biochemical parameters in animals and Mulmina treatment ameliorated these cognitive impairments by restoring antioxidant and maintaining cytokine levels. The combination of phytochemicals in Mulmina proved its possible ability to alleviate CICI without affecting chemotherapeutic efficiency and could pave the way for identifying treatment strategies to combat chemobrain.
AuthorsJeena John, Manas Kinra, Niraja Ranadive, Raghuvir Keni, Pawan Ganesh Nayak, Rajesh N Jagdale, Syed M Ahmed, Kaggundi V Raghavendra, Jayesh Mudgal, K Nandakumar
JournalScientific reports (Sci Rep) Vol. 12 Issue 1 Pg. 3072 (02 23 2022) ISSN: 2045-2322 [Electronic] England
PMID35197512 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • Antineoplastic Agents
  • Antioxidants
  • Cytokines
  • Phytochemicals
  • Plant Extracts
Topics
  • Animals
  • Antineoplastic Agents (adverse effects)
  • Antioxidants (metabolism)
  • Breast Neoplasms (drug therapy)
  • Cognitive Dysfunction (chemically induced, diagnosis, prevention & control)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Female
  • Mangifera (chemistry)
  • Medicine, Ayurvedic
  • Mice
  • Phytochemicals (administration & dosage, pharmacology)
  • Phytotherapy
  • Plant Extracts (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: